TY - JOUR
T1 - In vitro activity of BMY 28100, a new oral cephalosporin
AU - Steele, J.
AU - Edwards, B.
AU - Rissing, J.
PY - 1987/2
Y1 - 1987/2
N2 - BMY 28100, a new oral cephalosporin, demonstrated good in vitro activity against common gram-positive and gram-negative respiratory and urinary tract pathogens. Its activity was shown by microdilution techniques to be generally higher than those of ampicillin, cephalothin and cephalexin, but comparable to those of cefaclor and, except for Haemophilus spp. and Brantiamella spp., to amoxicillin/clavulanate.
AB - BMY 28100, a new oral cephalosporin, demonstrated good in vitro activity against common gram-positive and gram-negative respiratory and urinary tract pathogens. Its activity was shown by microdilution techniques to be generally higher than those of ampicillin, cephalothin and cephalexin, but comparable to those of cefaclor and, except for Haemophilus spp. and Brantiamella spp., to amoxicillin/clavulanate.
UR - http://www.scopus.com/inward/record.url?scp=0023139206&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023139206&partnerID=8YFLogxK
U2 - 10.1007/BF02097214
DO - 10.1007/BF02097214
M3 - Article
C2 - 3494601
AN - SCOPUS:0023139206
SN - 0722-2211
VL - 6
SP - 111
EP - 113
JO - European Journal of Clinical Microbiology
JF - European Journal of Clinical Microbiology
IS - 1
ER -